Detailed financial statements for Arch Capital Group Ltd. (ACGL): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products in the United States, Canada, Bermuda, the United Kingdom, Europe, and Australia. The company operates through three segments: Insurance, Reinsurance, and Mortgage.
Analysis Summary
Arch Capital Group Ltd. reported revenue of $19.93B in the most recent fiscal year, growing at a 5-year CAGR of 19.2%. Net income reached $4.40B, with a 25.6% 5-year CAGR.
Trailing-twelve-month margins: gross margin 49.4%, operating margin 26.4%, net margin 23.2%. Free cash flow grew at 16.6% CAGR over 5 years.
At $107.79 (closing price, November 3, 2026), ACGL trades at a P/E of 8.81 and an ROE of 18.35%. Market capitalisation stands at $36.8B, placing it among large-cap names.
Balance sheet quality for ACGL: debt-to-equity ratio of 0.19, current ratio of 1.22 over the last 12 months, net cash position of $8.81B at the end of the last fiscal year. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is strong: free cash flow of $6.13B represents 139% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.45B | $5.37B | $5.47B | $6.78B | $8.29B | $8.92B | $9.66B | $13.29B | $17.44B | $19.93B |
| Cost of Revenue | $2.85B | $3.74B | $3.70B | $3.97B | $5.69B | $5.89B | $6.77B | $8.56B | $10.99B | $12.52B |
| Gross Profit | $1.60B | $1.63B | $1.78B | $2.81B | $2.60B | $3.04B | $2.89B | $4.74B | $6.45B | $7.41B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $81.7M | $83.8M | $79.0M | $80.1M | $82.0M | $78.0M | $95.0M | $102.0M | $1.67B | 0 |
| Operating Expenses | $791.4M | $1.01B | $983.0M | $1.08B | $1.18B | $1.30B | $1.52B | $1.63B | $1.97B | $2.43B |
| Operating Income | $807.1M | $615.0M | $796.1M | $1.72B | $1.41B | $1.74B | $1.37B | $3.11B | $4.47B | $4.98B |
| EBITDA | $941.1M | $1.00B | $1.07B | $2.05B | $1.77B | $2.32B | $1.72B | $3.61B | $4.85B | $5.35B |
| Interest Expense | $66.3M | $117.4M | $120.5M | $120.9M | $143.5M | $139.0M | $131.0M | $133.0M | $141.0M | $148.0M |
| Pre-tax Income | $855.6M | $757.3M | $841.8M | $1.85B | $1.58B | $2.37B | $1.56B | $3.57B | $4.67B | $5.16B |
| Income Tax | $31.4M | $127.6M | $114.0M | $155.8M | $111.8M | $128.0M | $80.0M | -$873.0M | $362.0M | $760.0M |
| Net Income | $692.7M | $619.3M | $758.0M | $1.64B | $1.41B | $2.16B | $1.48B | $4.44B | $4.31B | $4.40B |
| EPS | $1.83 | $1.40 | $1.87 | $3.97 | $3.38 | $5.34 | $3.90 | $11.94 | $11.47 | $11.84 |
| EPS (Diluted) | $1.78 | $1.36 | $1.84 | $3.87 | $3.32 | $5.23 | $3.80 | $11.62 | $11.19 | $11.62 |
| Shares Outstanding (Diluted) | 374.2 M | 417.8 M | 412.9 M | 411.6 M | 410.3 M | 400.3 M | 377.6 M | 378.8 M | 381.8 M | 376.1 M |
Income Statement (Quarterly)
| Year | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|---|---|---|---|
| Revenue | $5.39B | $4.36B | $4.47B | $4.66B |
| Gross Profit | $2.33B | $2.27B | $2.28B | $2.45B |
| Operating Income | $1.39B | $1.15B | $1.22B | $1.23B |
| EBITDA | $1.50B | $1.21B | $1.29B | $1.28B |
| Net Income | $1.24B | $1.05B | $1.06B | $1.03B |
| EPS | $3.40 | $2.88 | $3.05 | $3.05 |
| EPS (Diluted) | $3.35 | $2.88 | $3.00 | $3.00 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $842.9M | $606.2M | $646.6M | $726.2M | $906.4M | $858.7M | $855.0M | $917.0M | $979.0M | $993.0M |
| Short-term Investments | $14.56B | $15.84B | $15.99B | $18.23B | $21.20B | $6.28B | $5.64B | $7.13B | $8.33B | $10.55B |
| Receivables | $4.90B | $5.65B | $6.30B | $8.24B | $8.55B | $10.49B | $12.09B | $13.82B | $16.40B | $7.99B |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 0 | 0 | 0 | 0 | 0 | $19.36B | $20.39B | $24.04B | $28.14B | $8.99B |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | $204.0M | $198.2M | $249.6M | $326.6M | $314.6M | $344.9M | $342.0M | $345.0M | $571.0M | $607.0M |
| Intangible Assets | $577.5M | $454.4M | $385.3M | $411.5M | $378.2M | $1.50B | $1.73B | $1.92B | $2.51B | $2.33B |
| Total Assets | $29.37B | $32.05B | $32.22B | $37.89B | $43.28B | $45.10B | $47.99B | $58.91B | $70.91B | $67.06B |
| Accounts Payable | $2.02B | $2.30B | $2.47B | $2.79B | $2.68B | $3.42B | $3.26B | $3.82B | $4.30B | $4.60B |
| Short-term Debt | $756.6M | $816.1M | $455.7M | $484.3M | $155.7M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | $27.49B | $30.98B | $35.88B | $44.32B | $7.44B |
| Long-term Debt | $1.73B | $1.73B | $1.73B | $1.87B | $2.86B | $2.72B | $2.73B | $2.73B | $2.73B | $2.73B |
| Total Liabilities | $20.06B | $21.81B | $21.78B | $25.57B | $29.29B | $31.55B | $35.07B | $40.55B | $50.09B | $42.85B |
| Retained Earnings | $8.00B | $8.56B | $9.43B | $11.02B | $12.36B | $14.46B | $15.89B | $20.30B | $22.69B | $27.05B |
| Total Equity | $8.25B | $9.20B | $9.44B | $11.50B | $13.11B | $13.55B | $12.91B | $18.35B | $20.82B | $24.21B |
| Total Debt | $2.49B | $2.55B | $2.19B | $2.36B | $3.02B | $2.72B | $2.73B | $2.73B | $2.73B | $2.73B |
| Net Debt | -$12.91B | -$13.90B | -$14.45B | -$16.60B | -$19.09B | -$4.41B | -$3.77B | -$5.32B | -$6.58B | -$8.81B |
| Working Capital | 0 | 0 | 0 | 0 | 0 | -$8.13B | -$10.59B | -$11.85B | -$16.18B | $1.54B |
Balance Sheet (Quarterly)
| Year | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|---|---|---|---|
| Cash & Equivalents | $993.0M | $914.0M | $1.11B | $1.15B |
| Total Assets | $67.06B | $81.45B | $85.18B | $84.08B |
| Total Liabilities | $42.85B | $57.26B | $61.15B | $61.08B |
| Total Equity | $24.21B | $24.19B | $24.03B | $22.99B |
| Total Debt | $2.73B | $2.73B | $4.29B | $4.29B |
Cash Flow (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $824.2M | $629.7M | $727.8M | $1.69B | $1.47B | $2.24B | $1.48B | $4.44B | $4.31B | $4.40B |
| Depreciation & Amortization | $19.3M | $125.8M | $105.7M | $82.1M | $69.0M | $82.0M | $106.0M | $95.0M | $235.0M | $193.0M |
| Stock-based Compensation | $56.6M | $67.8M | $55.8M | $66.4M | $71.3M | $88.0M | $88.0M | $93.0M | $133.0M | $148.0M |
| Change in Working Capital | $619.7M | $518.5M | $243.0M | $598.6M | $2.17B | $1.91B | $1.33B | $1.15B | $2.67B | $2.33B |
| Operating Cash Flow | $1.40B | $1.11B | $1.56B | $2.05B | $2.89B | $3.43B | $3.82B | $5.75B | $6.67B | $6.17B |
| Capital Expenditure | -$15.3M | -$22.8M | -$29.8M | -$37.8M | -$39.9M | -$41.4M | -$51.7M | -$52.0M | -$51.0M | -$44.0M |
| Acquisitions | -$1.99B | -$27.7M | 0 | 0 | 0 | -$1.10B | $1.55B | 0 | $852.0M | 0 |
| Stock Repurchased | -$77.7M | -$251.0M | -$382.9M | -$2.9M | -$83.5M | -$1.23B | -$586.0M | -$2.0M | -$24.0M | -$1.89B |
| Dividends Paid | -$28.1M | -$46.0M | -$41.6M | -$41.6M | -$41.6M | -$47.0M | -$40.0M | -$40.0M | -$1.91B | -$47.0M |
| Free Cash Flow | $1.38B | $1.09B | $1.53B | $2.01B | $2.85B | $3.39B | $3.76B | $5.70B | $6.62B | $6.13B |
Cash Flow (Quarterly)
| Year | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|---|---|---|---|
| Operating Cash Flow | $1.40B | $1.19B | $1.32B | $1.76B |
| Capital Expenditure | -$11.0M | -$8.0M | -$14.0M | -$11.0M |
| Free Cash Flow | $1.39B | $1.18B | $1.31B | $1.75B |
| Dividends Paid | -$10.0M | -$15.0M | -$10.0M | -$10.0M |
| Stock-based Compensation | $24.0M | $82.0M | $15.0M | $20.0M |
Growth & Margins (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +20.6% | +2.0% | +23.9% | +22.3% | +7.6% | +8.2% | +37.7% | +31.2% | +14.3% | |
| Net Income Growth (YoY) | -10.6% | +22.4% | +115.9% | -14.1% | +53.5% | -31.6% | +201.0% | -2.9% | +2.0% | |
| EPS Growth (YoY) | -23.5% | +33.6% | +112.3% | -14.9% | +58.0% | -27.0% | +206.2% | -3.9% | +3.2% | |
| Shares Change (YoY) | +11.7% | -1.2% | -0.3% | -0.3% | -2.4% | -5.7% | +0.3% | +0.8% | -1.5% | |
| FCF Growth (YoY) | -21.1% | +40.4% | +31.5% | +41.6% | +19.0% | +11.1% | +51.4% | +16.2% | -7.5% | |
| Gross Margin | 35.9% | 30.3% | 32.5% | 41.4% | 31.3% | 34.0% | 29.9% | 35.6% | 37.0% | 37.2% |
| Operating Margin | 18.1% | 11.5% | 14.5% | 25.4% | 17.1% | 19.5% | 14.2% | 23.4% | 25.7% | 25.0% |
| EBITDA Margin | 21.1% | 18.6% | 19.5% | 30.2% | 21.4% | 26.0% | 17.9% | 27.2% | 27.8% | 26.9% |
| Net Margin | 15.6% | 11.5% | 13.8% | 24.1% | 17.0% | 24.2% | 15.3% | 33.4% | 24.7% | 22.1% |
| FCF Margin | 31.0% | 20.3% | 27.9% | 29.6% | 34.3% | 37.9% | 39.0% | 42.9% | 38.0% | 30.7% |
| Effective Tax Rate | 3.7% | 16.8% | 13.5% | 8.4% | 7.1% | 5.4% | 5.1% | -24.5% | 7.7% | 14.7% |
Per-Share Data (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF Per Share | $3.69 | $2.61 | $3.70 | $4.88 | $6.94 | $8.46 | $9.97 | $15.04 | $17.34 | $16.29 |
| Dividends Per Share | $0.08 | $0.11 | $0.10 | $0.10 | $0.10 | $0.12 | $0.11 | $0.11 | $4.99 | $0.12 |
| Shares Outstanding (Basic) | 362.4 M | 404.1 M | 404.3 M | 401.8 M | 403.1 M | 391.7 M | 368.6 M | 368.7 M | 372.5 M | 369.0 M |
What to look at in Insurance
Insurers earn in 2 ways: underwriting well (combined ratio) and investing the float. Buffett built Berkshire that way.
- Op Margin 5y (Combined Ratio proxy) — Combined ratio proxy when our data does not include it. ≥10% 5y average = underwriting discipline (CR <100%)
- Book Value / Share growth — How Buffett measures Berkshire. The real value shareholders accumulate
- Debt / Equity — Leveraged insurers fail fast under catastrophes
- P/B (Price / Book) — Insurers are valued by book multiple. Here it is crossed with ROE (quality × valuation)
- Dividend growth streak — Consecutive years raising dividend per share — solid insurers stack decades
Profitability
| Return on Equity | 18.35% |
| Return on Invested Capital | 13.79% |
| Return on Assets | 5.21% |
| Gross Margin | 49.40% |
| Operating Margin | 26.40% |
| Net Margin | 23.19% |
Financial Health
| Debt / Equity | 0.19 |
| Current Ratio | 1.22 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 1.63 |
Key Ratios (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 15.72 | 21.61 | 14.29 | 10.80 | 10.67 | 8.32 | 16.10 | 6.22 | 8.05 | 8.10 |
| P/B | 1.26 | 1.33 | 1.14 | 1.50 | 1.11 | 1.29 | 1.79 | 1.49 | 1.65 | 1.46 |
| P/S | 2.34 | 2.28 | 1.97 | 2.54 | 1.75 | 1.95 | 2.40 | 2.06 | 1.97 | 1.78 |
| Gross Margin | 35.9% | 30.3% | 32.5% | 41.4% | 31.3% | 34.0% | 29.9% | 35.6% | 37.0% | 37.2% |
| Operating Margin | 18.1% | 11.5% | 14.5% | 25.4% | 17.1% | 19.5% | 14.2% | 23.4% | 25.7% | 25.0% |
| Net Margin | 15.6% | 11.5% | 13.8% | 24.1% | 17.0% | 24.2% | 15.3% | 33.4% | 24.7% | 22.1% |
Related companies: CB · WRB · MKL · EG · RNR · AFG · KNSL · AXS
Explore sector: Financial Services · Insurance - Diversified
More sections of ACGL: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks